U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 206321

SAXENDA (LIRAGLUTIDE)
18MG/3ML (6MG/ML)
Marketing Status: Prescription
Active Ingredient: LIRAGLUTIDE
Proprietary Name: SAXENDA
Dosage Form; Route of Administration: SOLUTION; SUBCUTANEOUS
Strength: 18MG/3ML (6MG/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N206321
Product Number: 001
Approval Date: Dec 23, 2014
Applicant Holder Full Name: NOVO NORDISK INC
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top